Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
1-(aminomethyl)cyclohexaneacetic acid hydrochloride
EC Number:
262-075-8
EC Name:
1-(aminomethyl)cyclohexaneacetic acid hydrochloride
Cas Number:
60142-95-2
Molecular formula:
C9H17NO2.ClH
IUPAC Name:
2-[1-(aminomethyl)cyclohexyl]acetic acid hydrochloride

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Remarks:
steril
Doses:
Dose volume of 10 ml/kg of body weight for each animal.
No. of animals per sex per dose:
3 female animals was dosed at a level of 2000 mg/kg
Control animals:
yes

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No deaths occurred in any animal dosed at 2000 mg/kg body weight. The first three animals dosed (step 1) showed piloerection starting from 30 minutes after dosing to Day 2. A single animal additionally showed reduced activity and brown staining on the muzzle from 30 minutes to 4 hours after dosing. Recovery was completed by Day 3.
The 3 animals of the second sub-group treated at the same dose level (step 2) showed piloerection starting from 30 minutes after dosing up to 4 hours after dosing. Recovery was completed by Day 2.
A single animal showed hairloss of the sacral region from Day 9 to Day 14, recovery occurring by Day 15. This clinical sign has no toxicological significance.
Body weight:
No relevant body weight change was recorded after treatment in animals dosed at 2000 mg/kg body weight (steps 1 and 2).
A single female belonging to the first subgroup (step 1) showed a very slight body weight loss (approximately 1-2% of the body weight) from Day 2 to Day 8, recovery occurring by Day 15. This loss has no toxicological significance.

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The LD50 to be greater than 2000 mg/kg body weight.